FDA recall record

Migo Trading FLOWFLEX SARS-COV-2 Antigen Rapid Test (Self-Testing), 1 Test recall — FDA Z-0421-2022

Devices are determined to be inconsistent with the firm's Emergency Use Authorization (EUA). This product has not been authorized for emergency use and…

Class IIclassification
Z-0421-2022official record ID
Jan 5, 2022report date

Recall record at a glance

Official recordZ-0421-2022
CategoryMedical Device Recalls
ClassificationClass II
FDA record statusOngoing
Recalling firmMigo Trading LLC
Report dateJan 5, 2022
Recall initiation dateNov 4, 2021
Quantity200,100 units
LocationDayton, NV, United States

Official product description

FLOWFLEX SARS-COV-2 Antigen Rapid Test (Self-Testing), 1 Test

Why the product was recalled

Devices are determined to be inconsistent with the firm's Emergency Use Authorization (EUA). This product has not been authorized for emergency use and the test cannot be determined to be adequately validated for the stated intended use.

Distribution information

NY

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.